Enanta Pharmaceuticals | ENTA - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
AbbVie USD 508.97B 46.71B 2026-11
Amgen USD 247.94B 20.06B 2026-11
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
AstraZeneca USD 213.88B 23.43B 2026-11
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 33.38B 1.48B 2026-09
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Halozyme Therapeutics USD 15.62B 3.09B 2026-11
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Incyte USD 24.6B 1.95B 2026-09
Insmed USD 24.93B 1.82B 2026-09
Ionis Pharmaceuticals USD 5.75B 1.67B 2026-11
J&J USD 653.61B 42.25B 2026-09
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.23B 108M 2026-09
Merck USD 375.59B 17.09B 2026-11
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Novavax USD 1.09B 316M 2025-12
Pfizer USD 165.12B 1.71B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.65B 276M 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11